SMDD-Bench: Can LLMs Solve Real-World Small Molecule Drug Design Tasks?

Kevin Han, Renfei Zhang, Kathy Wei, Hamed Mahdavi, Niloofar Mireshghallah, Amir Farimani

arXiv:2605.21740 · 2026-05-23 공개 · arXiv · PDF

llm-agents chemical-reasoning smdd-bench scaffold-hopping lead-optimization pharmacophore-identification protein-targets autonomous-drug-design

Abstract

LLM agents have incredible potential for scientific discovery applications. However, the performance of LLM agents on real-world, small molecule drug design (SMDD) tasks across diverse chemistries and targets is unclear. Current evaluation methods are either ad hoc, too simple for real-world discovery, limited in scale, or restricted to single-turn question answering. In effort to standardize the evaluation of LLM agents on small molecule design, we introduce SMDD-Bench, a challenging, multi-turn, long-horizon agentic benchmark consisting of 502 guaranteed-solvable task instances spanning 5 task types: 2D Pharmacophore Identification, Interaction Point Discovery, Scaffold Hopping, Lead Optimization, and Fragment Assembly. SMDD-Bench tasks span a wide region of chemical space and involve 102 unique protein targets. Completely solving the benchmark would require having strong chemical and biological reasoning and 3D intuition, understanding specialized tool use, and displaying planning expertise over a limited number of oracle calls. We benchmark 7 frontier open and closed source LLMs and find even the most performant LLM, GPT5.4, solves only 40.2\% of tasks. We hope SMDD-Bench provides a standardized testbed to invigorate the field towards training and evaluating LLM agents for fully autonomous computational drug design. We host a public leaderboard at smddbench.com .

한국어 요약

📋 한 줄 요약

**[Drug Design / LLM Agent 벤치]** SMDD-Bench가 5 task·102 단백질 target에 걸친 502 guaranteed-solvable multi-turn long-horizon SMDD task 제공, 7 frontier LLM에서 최고 GPT5.4도 40.2%만 해결.

🎯 핵심 기여도

💡 핵심 아이디어

SMDD에서 LLM agent의 실효성은 multi-turn·long-horizon·실제 chemical 다양성을 포괄하는 guaranteed-solvable 벤치마크에서야 검증 가능하며, frontier 모델조차 40%대 해결률에 그친다는 사실이 자율 computational drug design 도달의 격차를 드러낸다.

🔬 기술적 접근법

📊 주요 결과

💭 의의 및 한계

**의의**: SMDD에서 LLM agent의 표준 multi-turn 평가 정립, 자율 computational drug design 진전의 명확한 격차 노출, 향후 학습·평가의 testbed 제공. **한계**: 502 task의 chemical 다양성 한정, oracle call·도구 환경의 sim-real 격차, scaffold hopping 등 task의 평가 객관성, 절대 성능이 여전히 낮음.

🚀 실용적 활용